The Global Needle Biopsy Market is projected to touch $677 million at a staggering 5.2% CAGR during the forecast period (2017-2023). Needle biopsy is used for taking fluid or tissue samples from bones, muscles and other organs including lungs or liver. It is this sample that helps a physician to determine the cause behind the ailment. Often needle biopsies are conducted on outpatient basis which means the patient will not require staying in a hospital overnight. They may be provided with a mild sedative from the intravenous (IV) line to help in relaxation and alleviating anxiety related to the procedure. Local anesthesia is given to numb the needle path.
Resting on the techniques of imaging used, the patient may either be lying down or stay upright. The core needle biopsy possesses higher detectability rate and efficiency compared to fine needle aspiration biopsy. The combination of both will help one attain utmost sensitivity and detectability. The two tests thus are complementary while its rate of effectiveness will be the highest when both tests are done simultaneously.
There are a couple of factors that is driving the growth of the needle biopsy market. Some of the market trends and factors in this market as per an analysis conducted by Market Research Future (MRFR) include rising cases of cancers, increasing use of biopsy needles, product development and fall in the cost of components and raw materials. On the flip side, the factors that are likely to hinder the growth of the needle biopsy market include rising uncertainty about reimbursement in the United States and growing stringent standards and regulation for medical devices.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/3830
Global Needle Biopsy Market – Key Players
Leading players profiled in the needle biopsy market include Argon Medical Devices, Inc, Kompass, Hakko co. ltd., Dickinson and Company, Becton, Möller Medical GmbH, C. R. Bard, Inc., Medax, Cardinal Health, Inc., Hologic, Inc., CareFusion Corporation, Cook Medical and Boston Scientific Corporation. Dec 2018-
Dec 2018- Researchers at the Indiana University have discovered that FNB (fine needle biopsy) under the ultrasound guidance had higher diagnostic samples with minimal passes in patients having solid lesions, chiefly in the pancreas compared to that done through FNA (fine needle aspiration).
Dec 2018- As per a new analysis published in Annals of Internal Medicine on January 5th, 2019, it has been stated that core needle biopsy is equally effective to diagnose breast cancer as open surgical procedures but with fewer complications. Data over 100 studies comparing various biopsy methods had been looked and it was discovered that surgical biopsy and core needle biopsy offered women with mostly similar results.
Global Needle Biopsy Market – Segmentation
Market Research Future report provides a comprehensive segmental analysis of the needle biopsy market on the basis of type, utility and application.
Based on type, it is segmented into image-guided biopsy, vacuum-assisted biopsy, core needle biopsy and fine-needle aspiration biopsy. Of these, the vacuum-assisted biopsy will have the maximum share in the needle biopsy market.
Based on utility, the needle biopsy market is segmented into reusable and disposable.
Based on applications, it is segmented into inflammation, infection, tumor and others.
Global Needle Biopsy Market – Regional Analysis
Based on region, the needle biopsy market covers growth opportunities and latest trends across North America, Europe, Asia Pacific, the Middle East and Africa. US has the utmost share in the market owing to higher expenditure on healthcare and favorable reimbursement scenarios. The country’s prompt uptake of latest technology is a vital driver of the global needle biopsy market. Europe has the second biggest share owing to rising awareness and higher disposable income. The market in the APAC region is the fastest growing owing to huge unmet needs that is led by India and China. On the other hand, the needle biopsy market in the Middle East and Africa is led by the gulf nations UAE and Saudi Arabia. The poor regions in Africa is likely to be laggard owing to poor healthcare penetration and poor political and economic conditions.
Browse Complete 110 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/needle-biopsy-market-3830
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312